Imagine a medicine that possesses a sense of smell. A therapeutic agent that can navigate the vast, complex wilderness of the human body and ‘sniff out’ the difference between healthy tissue and a lethal tumor. This is not the plot of a science fiction novel; it is the life’s work of Yana Reshetnyak. As the President and CEO of pHLIP, Inc., Yana has pioneered a technology that targets the one universal hallmark of disease: Acidity.
It is a story of a physicist at the helm of a mission: envisioning a disease-free future. And by doing precisely that, Yana’s journey is rooted in the precision of physics. Since 2004, she has ascended the ranks of the University of Rhode Island, bridging the gap between membrane biophysics and radiation oncology. But Yana is no ivory-tower academic. As an Influential Female Executive in 2026, she has successfully transitioned her ‘pH-Low Insertion Peptide’ (pHLIP®) technology from the lab bench to a clinical-stage powerhouse. Her dual roles as a URI Professor and a Commissioner for the RI Atomic Commission highlight a leader who understands the weight of both discovery and responsibility.
The pHLIP® Revolution: A Trojan Horse for Cancer
At the heart of pHLIP, Inc. lies a proprietary technology that acts like a molecular ‘Trojan Horse.’ Cancerous and inflamed tissues are metabolically hyperactive and, as a result, acidic. While traditional treatments often fire blindly, pHLIP® peptides are engineered to remain dormant until they hit these acidic ‘hot spots.’ Once there, they anchor themselves to the cell surface or translocate directly into the cell, delivering imaging agents or lethal drugs, or gene regulating agents with surgical accuracy.
A Strategy of Collaboration and Sovereignty
Under Yana’s stewardship, pHLIP, Inc. has built a formidable intellectual fortress. By exclusively licensing patents from global titans like Yale, the University of Rhode Island, and the Memorial Sloan Kettering Cancer Center, she has ensured that her company is the sovereign leader of pH-targeted therapy. Her business strategy is as precise as her science: commercialize internal pipelines of PDCs while partnering with global biopharma giants to enhance the safety and efficacy of their own drug candidates.
The Integrity of an Executive Philosophy
In the unpredictable climate of 2026, where capital moves faster than the scientific process, Yana is quietly leading beyond what most leaders will achieve; she has found the perfect balance. This is accomplished by way of her ‘leadership style’, which is as focused on people (their energy) and reactions to one another as it is on being precise strategically.
Instead of leading through the distance of a title, like CEO, Yana leads through the reflection of her actions. As such, Yana believes that the empathy necessary to encourage and guide a team through the ‘valley of death’ (the fragile phase of clinical trials) is achieved through shared sacrifice. When uncertainty exists or a technical issue arises, Yana can be found working next to her researchers, providing the same meticulous approach to her own work (that she expects from her team). “I apply the same criteria for my work that I expect of my team. When a leader models the behavior they want from others, the team recognizes the leader’s commitment, fostering reciprocating support and understanding throughout the transition,” explains Yana.
The Sanctity of the Data: Refusing the Shortcut
In an era of ‘move fast and break things,’ Yana is a vocal advocate for the ‘Proof of Concept’ (PoC) as a sacred milestone. At pHLIP, Inc., decisions are not made based on market hype or investor sentiment, but on the cold, hard reality of scientific studies. Yana’s non-negotiable value is a refusal to ‘cut corners.’ She understands that in the business of saving lives, a half-baked result is worse than no result at all. By prioritizing the time necessary to obtain robust, unshakeable data, she has built a business culture that prizes truth over convenience.
Yana adds, “Our business is science-centered, and the results of scientific studies drive our decisions. My core guiding principle is a reliance on solid data. I refuse to ‘cut corners’; instead, I prioritize investing the time necessary to obtain a robust Proof of Concept.”
Persistence, Agility, and the Architecture of Trust
Yana’s experiences at the lab set the foundations of her tenacity – a characteristic at the core of scientific progress. However, making the transition from the unchanging principles of physics to the constantly changing forces of the biopharmaceutical industry quickly taught Yana that hard-headedness isn’t always the most effective strategy. To lead pHLIP through the haze of change in 2026, she needed not just persistence but an eye for timing and an emotional tolerance for taking a chance.
The Scientist’s Paradox: Persistence vs. Flexibility
In the world of research, years of trial and error are expected. Yana learned early on that there are many paths to get from point A to point B in business, and the quickest way from point A to point B isn’t necessarily a straight line. The greatest threat to a business leader is not to stay ‘stuck in the past’, i.e., act out of inertia – to continue following a pattern simply because that was what was chosen previously. Being current and relevant requires an evolutionary change in one’s thinking by combining the scientifically determined persistence that one is born with and an attitude of strategic adaptability. “As a scientist, persistence is second nature to me. However, because the business path is rarely a straight line, it is vital to avoid acting out of mere inertia. Effective leadership requires a fine balance between persistence and flexibility,” says Yana.
Staying Relevant: The Habit of the ‘Active Listener’
In rapidly evolving industries such as biotechnology, relevance can shift in a matter of moments. Yana maintains her competitive edge by staying deeply engaged with the latest scientific research and continuing education, following peer-reviewed journals and business publications with the same intensity that defined her early research career. Yet, what truly differentiates her leadership is her commitment to being an active listener.
By prioritizing the perspectives of her team, collaborators, and scientific partners, she ensures that pHLIP, Inc. remains a dynamic ecosystem where the most insightful ideas, rather than the loudest voices shape strategic direction. This approach has directly influenced the company’s newest areas of innovation. One such direction currently under active development includes the design of enhanced pHLIP (e-pHLIP) and, through a strategic partnership with CordenPharma, the introduction of pHLIP-coated lipid nanoparticles (pHLIP-LNP).
Both e-pHLIP and pHLIP-LNPs are being developed to enable the intracellular delivery of cell-impermeable, polar, and large gene-based therapeutics, including siRNA, RNA, and DNA. She sees this as a critical application of pHLIP technology, one that not only responds to emerging scientific needs but also positions the company at the forefront of modern medical and therapeutic innovation. Through attentive leadership and collaborative insight, she ensures that pHLIP’s evolution remains both scientifically relevant and future focused.
The Architecture of Trust: Relationships as a Support System
Within the high-stress and high-risk world of clinical trial development, the ultimate stabilizing factor is trust. For Yana, creating a high-performing team is more than just transactional efficiency; it involves building strong, enduring relationships over time through a truly character-driven and people-centric approach. She does not see her employees or partners simply as transactional assets; rather, they provide her with one of the most essential elements of a supportive community—the ability to support each other when facing challenging times.
“I place a very high value on trust, and I also place significant emphasis on developing long-term relationships with my partners,” says Yana. “The investment that I put into continuing to stay connected to them during times of transition or change is a great source of both business and personal benefit as well as a support system in times of need,” she adds.
Yana is redefining what it means to be a modern executive by integrating intellectual humility with relational depth. She represents how a leader can be unwavering in their principles while also being highly adaptable in their style. Ultimately, Yana has set a course for the technology of pHLIP® to execute on its primary goal—helping to save human lives by mastering the essential physics of the human body.
The Symphony of Art and Science: The Heart of Yana’s Leadership
Yana’s experience in biotech leadership has been both rewarding and isolating. The reclusive nature of leading at the highest level of biotechnology has made it necessary for Yana to seek refuge during her times of doubt as a clinical-stage entrepreneur. Her greatest strength is rooted in her career’s intermix of the artistry in her work and the rigor of her scientific education, and she has a close-knit group of kindred spirits that inspire her.
The Partner in Discovery: A Shared Scientific Life
At the core of Yana’s world is a partnership that transcends the home and the lab. Her husband, Oleg Andreev, is not only a scientist and fellow professor at the University of Rhode Island but also the co-founder of pHLIP, Inc. Together, they have navigated the arduous path of transforming a biophysical theory into a therapeutic reality. The person who is Yana’s strongest supporter is Oleg, who speaks both to her heart and her mind through science. Yana states, “My husband, Oleg Andreev, is my best friend and biggest supporter in helping me pursue the vision we created for PureTech.” Oleg has been the primary source of encouragement for Yana on her uncertain journeys.
The Artistic Counterpoint: A Daughter’s Vision
If Yana’s world is defined by the precision of physics, her daughter Stefania provides the essential counterpoint of color and form. As someone who earned a painting degree from the Rhode Island School of Design and from the School of the Art Institute of Chicago, Stefania continues to push the boundaries of Yana’s creativity and ability to think differently. As Yana and Stefania explore museums, attend concerts, and discuss artistic subtleties together, Yana often reflects on her reason for being in business: to save lives and to create beautiful opportunities to enhance the lives of those individuals through an artistic lens.
The Intellectual Salon: Wine, Art, and Innovation
The journey of pHLIP, Inc. is also a story of lifelong friendship. Donald Engelman, a professor at Yale and another co-founder, along with his wife Arlene, represents a unique support system. Their frequent gatherings are not merely social; they are ‘intellectual salons’ where the boundaries between art, science, and business dissolve over fine wine and shared meals. This community of thinkers provides the clarity Yana needs to steer pHLIP, Inc. through the volatile waters of 2026. She says, “We frequently discuss art, science, and business, sharing nice meals and wine together. These moments of connection with close friends and family are where I find the inspiration to continue our mission. Leadership should never be a lonely journey.”
